Brake Rachael Louise 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Brake Rachael Louise
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+570,800→ 570,800 totalExercise: $0.47Exp: 2032-02-01→ Common Stock (570,800 underlying)
Footnotes (1)
- [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023.